BPMC - Blueprint Medicines Corporation (BPMC) CEO Jeff Albers on Q2 2021 Results - Earnings Call Transcript
Blueprint Medicines Corporation (BPMC) Q2 2021 Earnings Conference Call July 29, 2021 08:30 AM ET Company Participants Kristin Hodous - Senior Manager-Investor Relations Jeff Albers - Chief Executive Officer Christy Rossi - Chief Commercial Officer Becker Hewes - Chief Medical Officer Mike Landsittel - Chief Financial Officer Conference Call Participants Salveen Richter - Goldman Sachs Marc Frahm - Cowen Dane Leone - Raymond James Reni Benjamin - JMP Securities Peter Lawson - Barclays David Lebowitz - Morgan Stanley Benjamin Kallo - Baird Michael Schmidt - Guggenheim Partners Andrew Berens - SVB Leerink Arlinda Lee - Canaccord Presentation Operator Good morning everyone. My name is Seth, and I will be your conference operator for today. At this time, I would like to welcome everyone to the Blueprint Medicines Second Quarter 2021 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks,
For further details see:
Blueprint Medicines Corporation (BPMC) CEO Jeff Albers on Q2 2021 Results - Earnings Call Transcript